In 2023, Saudi Arabia's pharmaceuticals market was worth US$ 9.2 billion. The IMARC Group forecasts it will grow to US$ 11.5 billion by 2032, at a CAGR of 2.52% from 2024 to 2032. Factors driving this growth include a rising population, more chronic diseases, government healthcare improvements, increased spending, technological advances, partnerships in the pharmaceutical sector, a ri... https://www.imarcgroup.com/saudi-arabia-pharmaceuticals-market